Observed and predicted mortality of patients with severe sepsis and septic shock;Beobachtete und vorhergesagte Mortalität bei Patienten mit schwerer Sepsis und septischem Schock: Ein Vergleich des APACHE II mit dem SAPS II Score

Intensivmedizin und Notfallmedizin

Volumn 34, Issue 5, 1997, Pages 416-425

  Wolf, M ^a   Buggisch, P ^a   Tilov, M ^a   Kreymann, G ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

APACHE II; Intensive score; Prognosis; SAPS II; Sepsis

Indexed keywords

EID: 2542600754     PISSN: 01753851     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003900050068     Document Type: Article

References (37)

1. Apolone G, Bertolini G, D'Amico R, Iapichino G, Cattaneo A, De Salvo G, Melotti RM (1996) The performance of SAPS II in a cohort of patients admitted to 99 Italian ICUs: results from GiViTI. Int Care Med 22:1368-1378
2. Bastos PG, Knaus WA, Zimmermann JE, Magalhaes AJ, Sun X, Wagner DP. The Brazil APACHE III Study Group (1996) The importance of technology for achieving superior outcomes from intensive care. Int Care Med 22:664-669
3. Bernardin G, Pradier C, Tiger F, Deloffre P, Mattei M (1996) Blood pressure and arterial lactate level are early indicator of short-term survival in human septic shock. Int Care Med 22:17-25
4. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, Mercier JC, Offenstadt G, Régnier B, The French ICU Group for Severe Sepsis (1995) Incidence, risk factors and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. JAMA 274:968-974
5. Castella X, Artigas A, Bion J, Kari A, The European/North American Severity Study Group (1995) A comparison of severity of illness scoring systems for intensive care unit patients: Results of a multicenter, multinational study. Crit Care Med 23:1327-1335
6. Dhainaut JF, Tenaillon A, Le Tulzo Y, Schlemmer B, Solet JP, Wolff M, Holzapfel L, Zeni F, Dreyfuss D, Mira JP, De Vathaire F, Guinot P, The CB0006 Sepsis Syndrome Study Group (1994) Platelet-activating factor receptor antagonist BN52021 in the treatment of severe sepsis: A randomized, double blind, placebo-controlled, multicenter clinical trial. Crit Care Med 22:1720-1728
7. Dhainaut JF, Vincent JL, Richard C, Lejeune P, Martin C, Firobe L, Stephens S, Key MU, Sopwith M, The CDP571 Study Group (1995) CDP571, a humanized antibody to human tumor necrosis factor-α: Safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. Crit Care Med 23:1461-1469
8. Fisher CJ, Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, Iberti TJ, Rackow EC, Shapiro MJ, Greenman RL, Reines D, Shelly MP, Thompson BW, LaBrecque JF, Catalano MA, Knaus WA, Sadoff JC, The phase III rhIL-1ra Sepsis Syndrome Study Group (1994a) Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from an randomized double-blind, placebo-controlled trial. JAMA 271:1836-1843
9. Fisher CJ, Slotman GJ, Opal SM, Pribble JP, Bone RC, Emmanuel G, Ng D, Bloedow DC, Catalano MA, The II-1ra Sepsis Syndrome Study Group (1994b) Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, openlabel, placebo-controlled multicenter trial. Crit Care Med 22:12-21
10. Fisher CJJ, Opal SM, Dhainaut JF, Stephens S, Zimmerman JL, Nightingale P, Harris SJ, Schein RMH, Panacek EA, Vincent JL, Foulke GE, Warren EL, Garrard C, Park G, Bodmer MW, Cohen J, van der Linden CJ, Cross AS, Sadoff JC, The CB0006 Sepsis Syndrome Study Group (1993) Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. Crit Care Med 21:318-327
11. Freid MA, Vosti KL (1968) The importance of underlying disease in patients with gram-negative bacteremia. Arch Intern Med 121:418-423
12. Friedland JS, Porter JC, Daryanani S, Bland JM, Screaton NJ, Vesely MJJ, Griffin GE, Bennett ED, Remick DG (1996) Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (Apache) III scores and survival in patients in an intensive care unit. Crit Care Med 24:1775-1781
13. Goldhill DR, Withington PS (1996) The effect of casemix adjustment on mortality as predicted by APACHE II. Int Care Med 11:415-419
14. Jacobs S, Chang RWS, Lee B (1988) Audit of intensive care: a 30 month experience using the APACHE II severity of disease classification system. Int Care Med 14:567-574
15. Knaus WA, Wagner DP, Draper EA, Zimmermann JE, Bergner M, Bastos PG, Sirio CA, Murphy DJ, Lotring T, Damiano A, Harrel FE (1991) The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 100:1619-1636
16. Knaus WA, Harrell FE, Fisher CJ, Wagner DP, Opal SM, Sadoff JC, Draper EA, Walawander CA, Conboy K, Grasela TH (1993) The clinical evaluation of new drugs for sepsis. A prospective study design based on survival analysis. JAMA 270:1233-1241
17. Knaus WA, Draper EA, Wagner DP (1985) APACHE II: A severity of disease classification system. Crit Care Med 13:818-829
18. Knaus WA, Sun X, Nystrom PO, Wagner DP (1992) Evaluation of Definition for Sepsis. Chest 101:1656-1662
19. Le Gall JR, Lemeshow S, Leleu G, Klar J, Huillard J, Rue M, Teres D, Artigas A (1995) Customized probability models for early severe sepsis in adult intensive care patients. Intensive Care Unit Scoring Group (see comments). JAMA 273:644-650
20. Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on an European/North American multicenter study. JAMA 270:2957-2963
21. Lemeshow S, Hosmer DWJ (1982) A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 115:92-106
22. Lemeshow S, Le Gall JR (1994) Modeling the severity of illness of ICU patients. A systems update. JAMA 272:1049-1055
23. Members of the American College of Chest Physician/Society of Critical Care Medicine Consensus Conference Committee (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874
24. Moreno R, Morais P (1997) Outcome prediction in intensive care: results of a prospective, multicentre, Portuguese study. Int Care Med 23:177-186
25. Park RE, Brook RH, Kosecoff J, Keesey J, Rubenstein L, Keeler E, Kahn KL, Rogers WH, Chassin MR (1990) Explaining variations in hospital death rates. Randomness, severity of illness, quality of care. JAMA 264:484-490
26. Pilz G, Kääb S, Neeser G, Class I, Schweigart U, Brähler A, Budjoso O, Neumann R, Werdan K (1991) Supplemental immunoglobulin (iv IgG) treatment in 163 patients with sepsis and septic shock. Infection 19:216-227
27. Pilz G, Fateh-Moghadam S, Viell B, Bujdoso O, Döring G, Marget W, Neumann R, Werdan K (1993) Supplemental immunoglobulin therapy in sepsis and septic shock - comparison of mortality under treatment with polyvalent i. v. immunoglobulin versus placebo. Theor Surg 8:61-83
28. Rapoport J, Teres D, Lemeshow S, Gehlbach S (1994) A method for assessing the clinical performance and cost-effectiveness of intensive care units: A multicenter inception cohort study. Crit Care Med 22:1385-1391
29. Reinhart K, Wiegand-Löhnert C, Grimminger F, Kaul M, Withington S, Treacher D, Eckart J, Willatts S, Bouza C, Krausch D, Stockenhuber F, Eiselstein J, Daum L, Kempeni J, The MAK 195F Sepsis Study Group (1996) Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: A multicenter, randomized placebo-controlled, dose-ranging study. Crit Care Med 24:733-742
30. Rowan KM, Kerr JH, Major E, McPherson JP, Short A, Vessey MP (1993a) Intensive care society's APACHE II study in Britain and Ireland - I: Variations in case mix of adult admissions to general intensive care units and impact on outcome. BMJ 307:972-977
31. Rowan KM, Kerr JH, Major E, McPherson JP, Short A, Vessey MP (1993b) Intensive care society's APACHE II study in Britain and Ireland - II: Outcome comparisons of intensive care units after adjustment for case mix by the American APACHE II method. BMJ 307:977-981
32. Rowan KM, Kerr JH, Major E, McPherson K, Short A, Vessey MP (1994) Intensive Care Society's acute physiology and chronic health evaluation (APACHE II) study in Britain and Ireland: A prospective, multicenter, cohort study comparing two methods for predicting outcome for adult intensive care patients. Crit Care Med 22:1392-1401
33. Salvo I, de Cian W, Musicco M, Langer M, Piadena R, Wolfler A, Montani C, Magni E, The Sepsis Study Group (1995). The Italian sepsis study: preliminary results on the incidence and evolution of sirs, sepsis, severe sepsis and septic shock. Int Care Med 21:S244-S249
34. Schuster HP (1996) Die Bedeutung von Scoresystemen für die Voraussage von Behandlungsergebnissen in der Intensivmedizin. Internist 37:1237-1243
35. Schuster HP, Wilts S, Ritschel P (1996) Analyse einer Ergebnisqualitätskontrolle in der Intensivmedizin mittels des Simplified Acute Physiology Score II. (Analysis of outcome quality control in intensive care medicine using the Simplified Acute Physiology Score II). Med Klinik 91:343-348
36. Sirio CA, Tajimi K, Tase C, Knaus WA, Wagner DP, Hirasawa H, Sakanishi N, Katsuya H, Taenaka N (1992) An initial comparison on intensive care in Japan and the United States. Crit Care Med 20:1207-1215
37. Zimmermann JE, Shortell SM, Rousseau DM, Duffy J, Gillies RR, Knaus WA, Devers K, Wagner DP, Draper EA (1993) Improving intensive care: Observations based on organizational case studies in nine intensive care units: A prospective, multicenter study. Crit Care Med 21:1443-1451